Exploring the role of retinal fluid as a biomarker for the management of diabetic macular oedema
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Exploring the role of retinal fluid as a biomarker for the management of diabetic macular oedema ; volume:38 ; number:1 ; day:21 ; month:7 ; year:2023 ; pages:54-60 ; date:1.2024
Eye ; 38, Heft 1 (21.7.2023), 54-60, 1.2024
- Urheber
-
Khoramnia, Ramin
Nguyen, Quan Dong
Kertes, Peter J.
Sararols Ramsay, Laura
Vujosevic, Stela
Anderesi, Majid
Igwe, Franklin
Eter, Nicole
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41433-023-02637-2
- URN
-
urn:nbn:de:101:1-2024031814034922630246
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Khoramnia, Ramin
- Nguyen, Quan Dong
- Kertes, Peter J.
- Sararols Ramsay, Laura
- Vujosevic, Stela
- Anderesi, Majid
- Igwe, Franklin
- Eter, Nicole
- SpringerLink (Online service)
Ähnliche Objekte (12)
Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO)
Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review
Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial
Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
External limiting membrane: retinal structural barrier in diabetic macular edema
Interpretation of SD-OCT imaging data in real-life conditions versus standardized reading centre analysis in eyes with diabetic macular oedema or macular oedema secondary to retinal vein occlusion: 24-month follow-up of the ORCA study
Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up
Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO)
Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review
Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial
Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
External limiting membrane: retinal structural barrier in diabetic macular edema
Interpretation of SD-OCT imaging data in real-life conditions versus standardized reading centre analysis in eyes with diabetic macular oedema or macular oedema secondary to retinal vein occlusion: 24-month follow-up of the ORCA study
Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up
Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO)
Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review
Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial
Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
External limiting membrane: retinal structural barrier in diabetic macular edema
Interpretation of SD-OCT imaging data in real-life conditions versus standardized reading centre analysis in eyes with diabetic macular oedema or macular oedema secondary to retinal vein occlusion: 24-month follow-up of the ORCA study